PharmaDispatch - PharmaDispatch

Latest News
Greg Hunt remains in health as PM unveils new ministry

Greg Hunt is back as health minister with Prime Minister Scott Morrison confirming his reappointment a short time ago.

Comment It is a very simple decision - it just involves some difficult first steps May 24, 2019
The cost-offset policy has been in place for around ten years – If the sector cannot produce the evidence of its negative impact, then there is no evidence of a problem and no point asking for more money in the PBS.
Latest News 'We will not agree on how to create the demise of the other's business' May 24, 2019
One of the most intense exchanges at PharmaDispatch 2019 was between DHL's Saul Resnick and Symbion's Brett Barons over the future of wholesale distribution.
Latest News MSAC not the 'sole solution' on gene and cell therapies May 24, 2019
The Medical Services Advisory Committee is the current but may not be the “sole solution” for evaluating gene and cell therapies.
Latest News Supply chain payment reform - 'mad' May 23, 2019
"So I think from our perspective, we think it is mad," said Symbion's Brett Barons at the PharmaDispatch 2019 conference.
Latest News HCV listing no 'Netflix' deal May 23, 2019
PBAC chair Professor Andrew Wilson has rejected the characterisation of the government's reimbursement of hepatitis C medicines as a 'Netflix' deal while expressing concern over the uptake of the therapies.
Latest News Cost recovery, resourcing and cost-offsets May 23, 2019
PBAC chair Professor Andrew Wilson discussed new cost-recovery measures, the importance of resourcing the evaluation and policy-making process, and the cost-offset policy.
Latest News PBAC chair: Review should consider new technologies May 22, 2019
"Personally, I would like to think this is an opportunity to think about the new environment and whether or not we want to incorporate gene and cell therapies within the National Medicines Policy," said PBAC chair Professor Andrew Wilson.
Latest News Trade and the PBS: A 'first-time' challenge May 22, 2019
"The difficulty we faced at that time is that pricing and reimbursement issues had never been discussed as part of a trade agreement," said BIO's Joseph Damond.
Latest News AusBiotech calls for action on R&D tax changes May 22, 2019
AusBiotech has called on the re-elected Coalition government to properly consider the impact of its proposed changes to the R&D Tax Incentive.
Guild says doctors 'misguided and ill-informed' on flu vax May 22, 2019
The Pharmacy Guild says criticism by doctors of the Tasmanian government’s decision to allow pharmacists to administer flu vaccines to children from the age of 10 is misguided and ill-informed.
Latest News There are 'reviews and there are reviews' May 21, 2019
According to PBAC chair Professor Andrew Wilson, the nature and extent of the review will be determined by the government, but his personal preference is for something more comprehensive.
Latest News New 'unit' to support consumer input May 21, 2019
The Department of Health has established a dedicated 'unit' focused on "structured projects of engagement with consumer and patient groups."
Latest News AusBiotech marks International Clinical Trials Day May 21, 2019
AusBiotech has marked International Clinical Trials Day (20 May) by highlighting the social and economic value they deliver to Australia.

News of the Day

Latest Video

Most Read

New Stories